Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Franceschini

Showing results (191-200 of 231) with videos related to

Pageof 24
Sort By:
Journal of Autoimmunity|November 15, 2021
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroupsClodoveo Ferri, Francesco Ursini, Laura Gragnani, et al.
Medicine|August 13, 2015
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter StudyLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Autoimmunity Reviews|July 6, 2026
The landscape of serum autoantibodies in lupus nephritisMaurizio Bruschi, Federico Alberici, Gabriella Moroni, et al.
Clinical Reviews in Allergy & Immunology|January 20, 2016
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative GroupLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Journal of Internal Medicine|December 10, 2025
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter studyFederica Pallotti, Camille Mettler, Matthias Papo, et al.
Autoimmunity Reviews|March 29, 2024
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidenceMaurizio Bruschi, Andrea Angeletti, Marco Prunotto, et al.
The Lancet. Rheumatology|February 8, 2026
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL studyChiara Tani, Chiara Cardelli, Luca Moroni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Autoimmunity Reviews|May 8, 2020
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, ItalyPaola Toniati, Simone Piva, Marco Cattalini, et al.
Pageof 24

Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
Journal of Autoimmunity|November 15, 2021
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroupsClodoveo Ferri, Francesco Ursini, Laura Gragnani, et al.
Medicine|August 13, 2015
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter StudyLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Autoimmunity Reviews|July 6, 2026
The landscape of serum autoantibodies in lupus nephritisMaurizio Bruschi, Federico Alberici, Gabriella Moroni, et al.
Clinical Reviews in Allergy & Immunology|January 20, 2016
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative GroupLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Journal of Internal Medicine|December 10, 2025
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter studyFederica Pallotti, Camille Mettler, Matthias Papo, et al.
Autoimmunity Reviews|March 29, 2024
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidenceMaurizio Bruschi, Andrea Angeletti, Marco Prunotto, et al.
The Lancet. Rheumatology|February 8, 2026
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL studyChiara Tani, Chiara Cardelli, Luca Moroni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Autoimmunity Reviews|May 8, 2020
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, ItalyPaola Toniati, Simone Piva, Marco Cattalini, et al.
Pageof 24